Cart
sales@molnova.com
Wnt pathway inhibitor 4
CAS No. 663214-57-1
Wnt pathway inhibitor 4( —— )
Catalog No. M37077 CAS No. 663214-57-1
Wnt pathway inhibitor 4 is a small molecule antimicrobial agent with antibacterial and antiproliferative activity against cancer cells.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 25MG | 28 | In Stock |
|
| 50MG | 39 | In Stock |
|
| 100MG | Get Quote | In Stock |
|
| 200MG | Get Quote | In Stock |
|
| 500MG | Get Quote | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NameWnt pathway inhibitor 4
-
NoteResearch use only, not for human use.
-
Brief DescriptionWnt pathway inhibitor 4 is a small molecule antimicrobial agent with antibacterial and antiproliferative activity against cancer cells.
-
DescriptionWnt pathway inhibitor 4 (compound 16D) is an anticancer agent that has anti-proliferative activity.
-
In Vitro——
-
In Vivo——
-
Synonyms——
-
PathwayGPCR/G Protein
-
TargetAntibacterial
-
RecptorAntibacterial
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number663214-57-1
-
Formula Weight431.24
-
Molecular FormulaC19H15BrN2O5
-
Purity>98% (HPLC)
-
Solubility——
-
SMILESC(#N)C=1C(C2=C(C=C3C(=C2)OCO3)OC1N)C4=CC(OC)=C(OC)C(Br)=C4
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1. Zhang H, et al. Design, synthesis and characterization of potent microtubule inhibitors with dual anti-proliferative and anti-angiogenic activities. Eur J Med Chem. 2018 Sep 5;157:380-396.?
molnova catalog
related products
-
Glyceryl monocaprate
Glyceryl monocaprate has inhibitory effect on Herpes Simplex Virus (HSV). It also offers an effective treatment for herpes labialiss.
-
NITD-349
NITD-349 is a novel, orally bioavailable mycobacterial membrane protein Large 3 (MmpL3) inhibitor with MIC of 23 nM against M tuberculosis H37Rv.
-
GSK-1322322
A novel antibacterial agent that targets bacterial peptide deformylase; demonstrates in vitro activity against MDR respiratory and skin infection pathogens.
